Article History
Accepted: 16 February 2021
First Online: 4 August 2021
Declarations
:
: KWLY consulted for and/or received honorarium from Novartis, F. Hoffmann La Roche, Takeda, Pfizer, TaiHo, Bristol-Myers Squib/Celgene, Paladin, Astex, and Otsuka. Received research funding from Astex, Novartis, Forma Therapeutics, Jazz, Onconova, F. Hoffmann La Roche, Genentech, and Tolero. ACS has consulted for and/or received honoraria from and/or received research support from AbbVie, Agios, Amgen, Astellas, Celgene/BMS, GlycoMimetics, Jazz, Novartis, Paladin, Pfizer, and Teva.